Cargando…

High Seroprevalence of Anti-SARS-CoV-2 Antibodies Among Ethiopian Healthcare Workers

BACKGROUND: COVID-19 pandemic has a devastating impact on the economies and health care system of sub-Saharan Africa. Healthcare workers (HWs), the main actors of the health system, are at higher-risk because of their occupation. Serology-based estimates of SARS-CoV-2 infection among HWs represent a...

Descripción completa

Detalles Bibliográficos
Autores principales: Gelanew, Tesfaye, Seyoum, Berhanu, Mulu, Andargachew, Mihret, Adane, Abebe, Markos, Wassie, Liya, Gelaw, Baye, Sorsa, Abebe, Merid, Yared, Muchie, Yilkal, Teklemariam, Zelalem, Tesfaye, Bezalem, Osman, Mahlet, Jebessa, Gutema, Atinafu, Abay, Hailu, Tsegaye, Habte, Antenehe., Kenea, Dagaga, Gadissa, Anteneh, Admasu, Desalegn, Tesfaye, Emmet, Bates, Timothy A., Bulcha, Jote, Tschopp, Rea, Tsehay, Dareskedar, Mullholand, Kim, Howe, Rawleigh, Genetu, Abebe, Tafesse, Fikadu G., Abdissa, Alemseged
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Journal Experts 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8312903/
https://www.ncbi.nlm.nih.gov/pubmed/34312618
http://dx.doi.org/10.21203/rs.3.rs-676935/v1
_version_ 1783729221384798208
author Gelanew, Tesfaye
Seyoum, Berhanu
Mulu, Andargachew
Mihret, Adane
Abebe, Markos
Wassie, Liya
Gelaw, Baye
Sorsa, Abebe
Merid, Yared
Muchie, Yilkal
Teklemariam, Zelalem
Tesfaye, Bezalem
Osman, Mahlet
Jebessa, Gutema
Atinafu, Abay
Hailu, Tsegaye
Habte, Antenehe.
Kenea, Dagaga
Gadissa, Anteneh
Admasu, Desalegn
Tesfaye, Emmet
Bates, Timothy A.
Bulcha, Jote
Tschopp, Rea
Tsehay, Dareskedar
Mullholand, Kim
Howe, Rawleigh
Genetu, Abebe
Tafesse, Fikadu G.
Abdissa, Alemseged
author_facet Gelanew, Tesfaye
Seyoum, Berhanu
Mulu, Andargachew
Mihret, Adane
Abebe, Markos
Wassie, Liya
Gelaw, Baye
Sorsa, Abebe
Merid, Yared
Muchie, Yilkal
Teklemariam, Zelalem
Tesfaye, Bezalem
Osman, Mahlet
Jebessa, Gutema
Atinafu, Abay
Hailu, Tsegaye
Habte, Antenehe.
Kenea, Dagaga
Gadissa, Anteneh
Admasu, Desalegn
Tesfaye, Emmet
Bates, Timothy A.
Bulcha, Jote
Tschopp, Rea
Tsehay, Dareskedar
Mullholand, Kim
Howe, Rawleigh
Genetu, Abebe
Tafesse, Fikadu G.
Abdissa, Alemseged
author_sort Gelanew, Tesfaye
collection PubMed
description BACKGROUND: COVID-19 pandemic has a devastating impact on the economies and health care system of sub-Saharan Africa. Healthcare workers (HWs), the main actors of the health system, are at higher-risk because of their occupation. Serology-based estimates of SARS-CoV-2 infection among HWs represent a measure of HWs’ exposure to the virus and a guide to the prevalence of SARS-CoV-2 in the community. This information is currently lacking in Ethiopia and other African countries. This study aimed to develop an in-house antibody testing assay, assess the prevalence of SARS-CoV-2 antibodies among Ethiopian high-risk frontline HWs. METHODS: A cross-sectional seroprevalence study was conducted among HWs in five public hospitals located in different geographic regions of Ethiopia. Socio-demographic and clinical data were collected using questionnaire-based interviews. From consenting HWs, blood samples were collected between December 2020 and February 2021, the period between the two peaks of COVID-19 in Ethiopia. The collected sera were tested using an in-house immunoglobin G (IgG) enzyme-linked immunosorbent assay (ELISA) for SARS-CoV-2 specific antibodies on sera collected from HWs. RESULTS: Of 1,997 HWs who provided a blood sample, demographic and clinical data, 50.5% were female, 74.0% had no symptoms compatible with COVID-19, and 29.0% had history of contact with suspected or confirmed patient with SARS-CoV-2 infection. The overall seroprevalence was 39.6%. The lowest (24.5%) and the highest (48.0%) seroprevalence rates were found in Hiwot Fana Specialized Hospital in Harar and ALERT Hospital in Addis Ababa, respectively. Of the 821 seropositive HWs, 224(27.3%) had history of symptoms consistent with COVID-19. A history of close contact with suspected/confirmed COVID-19 cases was strongly associated with seropositivity (Adjusted odds Ratio (AOR) =1.4, 95% CI 1.1–1.8; p=0.015). CONCLUSION: High SARS-CoV-2 seroprevalence levels were observed in the five Ethiopian hospitals. These findings highlight the significant burden of asymptomatic infection in Ethiopia, and may reflect the scale of transmission in the general population.
format Online
Article
Text
id pubmed-8312903
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher American Journal Experts
record_format MEDLINE/PubMed
spelling pubmed-83129032021-07-27 High Seroprevalence of Anti-SARS-CoV-2 Antibodies Among Ethiopian Healthcare Workers Gelanew, Tesfaye Seyoum, Berhanu Mulu, Andargachew Mihret, Adane Abebe, Markos Wassie, Liya Gelaw, Baye Sorsa, Abebe Merid, Yared Muchie, Yilkal Teklemariam, Zelalem Tesfaye, Bezalem Osman, Mahlet Jebessa, Gutema Atinafu, Abay Hailu, Tsegaye Habte, Antenehe. Kenea, Dagaga Gadissa, Anteneh Admasu, Desalegn Tesfaye, Emmet Bates, Timothy A. Bulcha, Jote Tschopp, Rea Tsehay, Dareskedar Mullholand, Kim Howe, Rawleigh Genetu, Abebe Tafesse, Fikadu G. Abdissa, Alemseged Res Sq Article BACKGROUND: COVID-19 pandemic has a devastating impact on the economies and health care system of sub-Saharan Africa. Healthcare workers (HWs), the main actors of the health system, are at higher-risk because of their occupation. Serology-based estimates of SARS-CoV-2 infection among HWs represent a measure of HWs’ exposure to the virus and a guide to the prevalence of SARS-CoV-2 in the community. This information is currently lacking in Ethiopia and other African countries. This study aimed to develop an in-house antibody testing assay, assess the prevalence of SARS-CoV-2 antibodies among Ethiopian high-risk frontline HWs. METHODS: A cross-sectional seroprevalence study was conducted among HWs in five public hospitals located in different geographic regions of Ethiopia. Socio-demographic and clinical data were collected using questionnaire-based interviews. From consenting HWs, blood samples were collected between December 2020 and February 2021, the period between the two peaks of COVID-19 in Ethiopia. The collected sera were tested using an in-house immunoglobin G (IgG) enzyme-linked immunosorbent assay (ELISA) for SARS-CoV-2 specific antibodies on sera collected from HWs. RESULTS: Of 1,997 HWs who provided a blood sample, demographic and clinical data, 50.5% were female, 74.0% had no symptoms compatible with COVID-19, and 29.0% had history of contact with suspected or confirmed patient with SARS-CoV-2 infection. The overall seroprevalence was 39.6%. The lowest (24.5%) and the highest (48.0%) seroprevalence rates were found in Hiwot Fana Specialized Hospital in Harar and ALERT Hospital in Addis Ababa, respectively. Of the 821 seropositive HWs, 224(27.3%) had history of symptoms consistent with COVID-19. A history of close contact with suspected/confirmed COVID-19 cases was strongly associated with seropositivity (Adjusted odds Ratio (AOR) =1.4, 95% CI 1.1–1.8; p=0.015). CONCLUSION: High SARS-CoV-2 seroprevalence levels were observed in the five Ethiopian hospitals. These findings highlight the significant burden of asymptomatic infection in Ethiopia, and may reflect the scale of transmission in the general population. American Journal Experts 2021-07-19 /pmc/articles/PMC8312903/ /pubmed/34312618 http://dx.doi.org/10.21203/rs.3.rs-676935/v1 Text en https://creativecommons.org/licenses/by/4.0/This work is licensed under a Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/) , which allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, so long as attribution is given to the creator. The license allows for commercial use.
spellingShingle Article
Gelanew, Tesfaye
Seyoum, Berhanu
Mulu, Andargachew
Mihret, Adane
Abebe, Markos
Wassie, Liya
Gelaw, Baye
Sorsa, Abebe
Merid, Yared
Muchie, Yilkal
Teklemariam, Zelalem
Tesfaye, Bezalem
Osman, Mahlet
Jebessa, Gutema
Atinafu, Abay
Hailu, Tsegaye
Habte, Antenehe.
Kenea, Dagaga
Gadissa, Anteneh
Admasu, Desalegn
Tesfaye, Emmet
Bates, Timothy A.
Bulcha, Jote
Tschopp, Rea
Tsehay, Dareskedar
Mullholand, Kim
Howe, Rawleigh
Genetu, Abebe
Tafesse, Fikadu G.
Abdissa, Alemseged
High Seroprevalence of Anti-SARS-CoV-2 Antibodies Among Ethiopian Healthcare Workers
title High Seroprevalence of Anti-SARS-CoV-2 Antibodies Among Ethiopian Healthcare Workers
title_full High Seroprevalence of Anti-SARS-CoV-2 Antibodies Among Ethiopian Healthcare Workers
title_fullStr High Seroprevalence of Anti-SARS-CoV-2 Antibodies Among Ethiopian Healthcare Workers
title_full_unstemmed High Seroprevalence of Anti-SARS-CoV-2 Antibodies Among Ethiopian Healthcare Workers
title_short High Seroprevalence of Anti-SARS-CoV-2 Antibodies Among Ethiopian Healthcare Workers
title_sort high seroprevalence of anti-sars-cov-2 antibodies among ethiopian healthcare workers
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8312903/
https://www.ncbi.nlm.nih.gov/pubmed/34312618
http://dx.doi.org/10.21203/rs.3.rs-676935/v1
work_keys_str_mv AT gelanewtesfaye highseroprevalenceofantisarscov2antibodiesamongethiopianhealthcareworkers
AT seyoumberhanu highseroprevalenceofantisarscov2antibodiesamongethiopianhealthcareworkers
AT muluandargachew highseroprevalenceofantisarscov2antibodiesamongethiopianhealthcareworkers
AT mihretadane highseroprevalenceofantisarscov2antibodiesamongethiopianhealthcareworkers
AT abebemarkos highseroprevalenceofantisarscov2antibodiesamongethiopianhealthcareworkers
AT wassieliya highseroprevalenceofantisarscov2antibodiesamongethiopianhealthcareworkers
AT gelawbaye highseroprevalenceofantisarscov2antibodiesamongethiopianhealthcareworkers
AT sorsaabebe highseroprevalenceofantisarscov2antibodiesamongethiopianhealthcareworkers
AT meridyared highseroprevalenceofantisarscov2antibodiesamongethiopianhealthcareworkers
AT muchieyilkal highseroprevalenceofantisarscov2antibodiesamongethiopianhealthcareworkers
AT teklemariamzelalem highseroprevalenceofantisarscov2antibodiesamongethiopianhealthcareworkers
AT tesfayebezalem highseroprevalenceofantisarscov2antibodiesamongethiopianhealthcareworkers
AT osmanmahlet highseroprevalenceofantisarscov2antibodiesamongethiopianhealthcareworkers
AT jebessagutema highseroprevalenceofantisarscov2antibodiesamongethiopianhealthcareworkers
AT atinafuabay highseroprevalenceofantisarscov2antibodiesamongethiopianhealthcareworkers
AT hailutsegaye highseroprevalenceofantisarscov2antibodiesamongethiopianhealthcareworkers
AT habteantenehe highseroprevalenceofantisarscov2antibodiesamongethiopianhealthcareworkers
AT keneadagaga highseroprevalenceofantisarscov2antibodiesamongethiopianhealthcareworkers
AT gadissaanteneh highseroprevalenceofantisarscov2antibodiesamongethiopianhealthcareworkers
AT admasudesalegn highseroprevalenceofantisarscov2antibodiesamongethiopianhealthcareworkers
AT tesfayeemmet highseroprevalenceofantisarscov2antibodiesamongethiopianhealthcareworkers
AT batestimothya highseroprevalenceofantisarscov2antibodiesamongethiopianhealthcareworkers
AT bulchajote highseroprevalenceofantisarscov2antibodiesamongethiopianhealthcareworkers
AT tschopprea highseroprevalenceofantisarscov2antibodiesamongethiopianhealthcareworkers
AT tsehaydareskedar highseroprevalenceofantisarscov2antibodiesamongethiopianhealthcareworkers
AT mullholandkim highseroprevalenceofantisarscov2antibodiesamongethiopianhealthcareworkers
AT howerawleigh highseroprevalenceofantisarscov2antibodiesamongethiopianhealthcareworkers
AT genetuabebe highseroprevalenceofantisarscov2antibodiesamongethiopianhealthcareworkers
AT tafessefikadug highseroprevalenceofantisarscov2antibodiesamongethiopianhealthcareworkers
AT abdissaalemseged highseroprevalenceofantisarscov2antibodiesamongethiopianhealthcareworkers